drugset / Trial / NCT02985736
Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
Phase 4
Completed
20 enrolled
Psoriasis Treatment Center of Central New Jersey
Sun Pharmaceutical Industries, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
Timeline
- Start
- 2016-09
- Primary completion
- 2017-01-27
- Completion
- 2017-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desoximetasone | Small molecule | 0.25 % | Topical |